客户发表文献

至今，GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次，处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果，再次证明GenScript 有能力帮助业内科学家Make research easy.

页码: 1/1 每页显示数量

Single-chain Fragment variable antibody targeting cholecystokinin-B receptor for pain reduction

Authors: K N Westlund, M A Montera, A E Goins, S R A Alles, M Afaghpour-Becklund, R Bartel, R Durvasula, A Kunamneni

Journal: Neurobiol Pain

PubMed ID: 34458647

Doi: 10.1016/j.ynpai.2021.100067

Products & Services: Monoclonal Antibody Services

A DNA-launched nanoparticle vaccine elicits CD8+ T-cell immunity to promote in vivo tumor control

Authors: Ziyang Xu, Neethu Chokkalingam, Edgar Tello-Ruiz, Megan C Wise, Mamadou A Bah, Susanne Walker, Nicholas J Tursi, Paul D Fisher, Katherine Schultheis, Kate E Broderick, Laurent Humeau, Daniel W Kulp and David B Weiner

Journal: American Association for Cancer Research

Doi: 10.1158/2326-6066.CIR-20-0061

Products & Services: Gene Synthesis Peptide Library Services Catalog Antibody

« 上一页
1
下一页 »

客户发表文献

资源中心

技术支持

关于我们